Democrats need an autopsy to figure out why 74 million Americans voted against them
USA Today· 2 hours agoIn spring 2013, after their defeat in the 2012 presidential election, the Republicans conducted an...
This vaccine calculator estimates when you'll be offered the COVID-19 vaccination
Cosmo via Yahoo News· 4 hours agoThe Oxford vaccine is now in full swing across the country, and the Moderna jab is expected to be...
After they were voted down in the fall, Wausau School District seeks approval for 2 modified...
Wausau Daily Herald· 2 hours agoAfter receiving feedback from voters, parents and the community, the Wausau School District will...
Unicharm joins Japan's quest for more N95 masks amid COVID wave
Nikkei Asian Review· 4 hours agoUnicharm, the Japanese consumer goods group known for diapers and feminine hygiene products, plans...
Sandy Spring Bancorp Inc (SASR) Q4 2020 Earnings Call Transcript
Motley Fool· 4 days agoNow, I'd like to turn the conference over to Mr. Daniel Schrider, President and CEO. This is Dan...
On its face, the Arab Spring was a spectacular failure. But is it really over?
Washington Post· 16 hours agoThe fall of Tunisian President Zine el-Abidine Ben Ali after a month of street protests in Tunis...
Johnson & Johnson Aims for 100 Million Vaccine Doses by Spring. The Stock Market Is Counting on It.
Barron s Online· 3 days ago“Johnson & Johnson is making a very large supply, going all out with its production both here in the...
A Virus-Plagued Rat Year Ends, and China Starts Afresh
TheStreet.com· 5 days agoIt was hitting just before the Spring Festival, a.k.a. Now in 2021, we again await Lunar New Year (also celebrated in Vietnam and Korea), and parts of Beijing are locked down ...
Perry: Assessing a potential Stafford-to-Patriots trade
NBC Sports· 2 days agoThe Patriots can't wait until the draft this spring to address the most important position on the...
Johnson & Johnson plans to have 100 million vaccines for Americans by spring, board member says
CNBC· 4 days agoJohnson & Johnson board member Dr. Mark McClellan told CNBC that "if the clinical trial works out,"...